Figure 5.
TN14003 antagonizes protective effects of marrow stromal cells. (A) Determination of cell viability by staining with DiOC6 and PI. Presented are contour maps of CLL B cells from one patient defining the relative green (DiOC6) and red (PI) fluorescence intensities of CLL cells on the horizontal and vertical axes, respectively. The vital cell population (DiOC6bright, PIexclusion) was determined for CLL cells cultured in the presence (top row) or absence (bottom row) of M2-10B4 cells and 72 hours after treatment with 10 μM F-ara-A and TN14003. The percentage of vital cells is displayed in each contour map. (B) CLL cells were cultured on M2-10B4 stromal cells and treated with 10 μM F-ara-A or the combination of F-ara-A and 10 μg/mL TN14003. Cell viability was measured 24, 48, and 72 hours after treatment, as indicated on the horizontal axis. Data represent the mean relative viability of CLL cells treated with 10 μM F-ara-A (▨) or 10 μM F-ara-A and TN14003 (▪) compared with the respective viability of CLL cells cultured on M2-10B4 stromal cells without F-ara-A or TN14003 (controls). Displayed are the mean ± SEM values of 10 patient samples (*P < .05).